FDA Puts Strict Limits on Johnson & Johnson Covid-19 Vaccine

FDA Puts Strict Limits on Johnson & Johnson Covid-19 Vaccine- Interviews Available with Dr./Vaccine Expert

Cited Story Link: https://www.cnn.com/2022/05/05/health/fda-johnson-johnson-vaccine-eua/index.html

Dean L. Fanelli, Ph.D., an expert on vaccines & is available for interviews.

The US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated. The FDA said in a statement that the change is being made because of the risk of a rare and dangerous clotting condition called thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.

About Dr. Dean Fanelli

Dean Fanelli, Ph.D. is a patent, regulatory, and transactional attorney in the Washington, DC office of Cooley LLP (www.cooley.com) focusing on issues related to the development, protection, and commercialization of biotech and pharmaceutical products. He is a regular on TV & Radio commenting on Covid-19 & Vaccines & also hosts his own podcast “Politics & Life Sciences Radio.”

Recent TV Appearance:

https://cheddar.com/media/health-experts-optimistic-after-early-pfizer-vaccine-data-shows-effectiveness

dru